Fact checked by Karen Cilli For anyone who's experienced the bodily takeover when a wave of anxiety hits—the racing heart, ...

and congestive heart failure. However, β blockers do not all share the same clinical outcomes with respect to efficacy or safety in many of these conditions. This is especially true in HF ...

It has been assumed that β-AR antagonists (β-blockers) have a direct favorable influence on the heart, but our results challenge this view, suggesting that β-blockers may also act directly in ...

Beta blockers are a heart medication—their main function, in simple terms, is to slow down the heart rate and lower blood pressure while treating heart conditions. It seems there’s a growing ...

Beta-blockers antagonize beta-1 and beta-2 receptors which are the usual targets of the sympathetic nervous system, including epinephrine and norepinephrine. This results in a decreased heart rate ...

A new study from the University of Bologna has raised concerns about a common blood pressure medication called beta-blockers.

BACKGROUND: Limited evidence exists on the prognostic role of continuing medical therapy in patients with heart failure (HF) and an ejection fraction (EF) that has improved over time. This study ...

The primary endpoint was a composite of the first occurrence of either hospitalization for worsening heart failure or cardiovascular death. Most patients (89%) were taking beta-blockers ...

Non-dihydropyridine calcium channel blockers act predominantly centrally to decrease heart rate (chronotropy) and contractility (inotropy). Calcium channel blockers are used to treat hypertension ...

Atenolol blocks beta-1 receptors, which are present on the heart. This medication is a beta-blocker, prescribed for high blood pressure and to prevent heart pain and recurrence of heart attacks.